Get Skinny
Jonas Whitlock

Health Reporter · Editorial staff

Jonas Whitlock

Writes the publication's comparison guides, weighing the options in medically supervised weight solutions side by side.

11 stories by Jonas Whitlock

Why Your Starting Dose Is Not Your Treatment Dose: GLP-1 Titration, ExplainedExplainer

Why Your Starting Dose Is Not Your Treatment Dose: GLP-1 Titration, Explained

Patients often judge a medication in the first four weeks, which is exactly when it is not yet doing its full job. Here is what titration actually is, why clinicians insist on it, and what a stalled or rushed schedule can cost you.

· Jonas Whitlock

What Actually Happens When You Stop a GLP-1 MedicationExplainer

What Actually Happens When You Stop a GLP-1 Medication

The biology of discontinuation is predictable, not mysterious. Here is what the data show about appetite rebound, weight regain, and how supervised programs plan for the off-ramp.

· Jonas Whitlock

The GLP-1 Plateau: Why Medically Supervised Weight Loss Stalls, and What Clinicians Actually Do NextExplainer

The GLP-1 Plateau: Why Medically Supervised Weight Loss Stalls, and What Clinicians Actually Do Next

Almost everyone on semaglutide or tirzepatide eventually stops losing weight. The plateau is not a failure of willpower or the drug. It is predictable physiology, and supervised programs plan for it.

· Jonas Whitlock

Why Your GLP-1 Dose Starts So Low: The Science of Titration, ExplainedExplainer

Why Your GLP-1 Dose Starts So Low: The Science of Titration, Explained

Patients often ask why the first months of medically supervised weight treatment feel like a slow ramp. The answer lies in gut physiology, receptor adaptation, and safety data, not clinic caution for its own sake.

· Jonas Whitlock

Muscle Matters: Why Lean Mass Preservation Is the Quiet Priority in Medical Weight LossExplainer

Muscle Matters: Why Lean Mass Preservation Is the Quiet Priority in Medical Weight Loss

Rapid weight loss on GLP-1 medications can take muscle along with fat. Here is what the physiology says, and what supervised programs actually do about it.

· Jonas Whitlock

Semaglutide vs Tirzepatide: What Adding a Second Hormone Pathway Actually ChangesExplainer

Semaglutide vs Tirzepatide: What Adding a Second Hormone Pathway Actually Changes

Both injectables suppress appetite, but they work through different receptor combinations. Here is a plain-English breakdown of the mechanisms, the trial numbers, and the practical tradeoffs patients ask about most.

· Jonas Whitlock

What Actually Happens When You Stop a GLP-1: The Physiology of Weight Regain, ExplainedExplainer

What Actually Happens When You Stop a GLP-1: The Physiology of Weight Regain, Explained

Stopping semaglutide or tirzepatide is not a willpower test. It is a hormonal event. Here is what the body does in the weeks after the last dose, and what supervised programs do about it.

· Jonas Whitlock

A person mid-lift with a barbell in a bright airy gym, candid documentary shot in natural lightLasting Change

Strength training on a GLP-1: the case for lifting

Rapid weight loss strips muscle along with fat. Lifting is how you keep what you want to keep.

· Jonas Whitlock

A calm minimalist bedroom with a made bed and soft morning light through linen curtainsLasting Change

Sleep and weight: the overlooked lever

You can do everything right with food and movement and still stall if you are not sleeping enough.

· Jonas Whitlock

An open jar of unscented moisturizer beside a folded towel on a warm neutral counterLasting Change

Caring for your skin through weight change

Supporting skin elasticity gives it the best chance to retract.

· Jonas Whitlock

Walking shoes and fresh whole foods on a wooden kitchen counter in warm daylightLasting Change

Sustainable weight loss beyond the scale

Why lasting change is about habits and health, not a number.

· Jonas Whitlock